FREE SHIPPING over $40
Horse Supplements USA English
Horse Supplements Canada EnglishSuppléments Équins Canada French
My Account
View Cart My Horses Track Orders Account Details My Subscriptions Update Address Payment Methods
Register/Login
0
Home/Equine Research Bank/J Virol/Attenuation of equine influenza viruses through truncations ...
Journal of virology2005; 79(13); 8431-8439; doi: 10.1128/JVI.79.13.8431-8439.2005

Attenuation of equine influenza viruses through truncations of the NS1 protein.

Abstract: Equine influenza is a common disease of the horse, causing significant morbidity worldwide. Here we describe the establishment of a plasmid-based reverse genetics system for equine influenza virus. Utilizing this system, we generated three mutant viruses encoding carboxy-terminally truncated NS1 proteins. We have previously shown that a recombinant human influenza virus lacking the NS1 gene (delNS1) could only replicate in interferon (IFN)-incompetent systems, suggesting that the NS1 protein is responsible for IFN antagonist activity. Contrary to previous findings with human influenza virus, we found that in the case of equine influenza virus, the length of the NS1 protein did not correlate with the level of attenuation of that virus. With equine influenza virus, the mutant virus with the shortest NS1 protein turned out to be the least attenuated. We speculate that the basis for attenuation of the equine NS1 mutant viruses generated is related to their level of NS1 protein expression. Our findings show that the recombinant mutant viruses are impaired in their ability to inhibit IFN production in vitro and they do not replicate as efficiently as the parental recombinant strain in embryonated hen eggs, in MDCK cells, or in vivo in a mouse model. Therefore, these attenuated mutant NS1 viruses may have potential as candidates for a live equine influenza vaccine.
Get Full Text
Publication Date: 2005-06-16 PubMed ID: 15956587PubMed Central: PMC1143746DOI: 10.1128/JVI.79.13.8431-8439.2005Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedIn
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research presents the establishment of a reverse genetics system for the equine influenza virus, using this system to create three mutant viruses. The findings shift prior understanding about the NS1 protein’s role in equine influenza, suggesting that the length of the protein doesn’t correspond with virus attenuation. The mutants produced show promise for future live vaccines.

Creation of the Reverse Genetics System and Mutant Viruses

  • The major focus of the study was to establish a plasmid-based reverse genetics system for the equine influenza virus. A reverse genetics system is an advanced mechanism through which researchers can manipulate the genome of a virus and observe the resulting effects.
  • Utilizing this system, the researchers managed to generate three mutant viruses. These mutated versions encoded carboxy-terminally truncated NS1 proteins, meaning that the NS1 proteins created were shorter than those found in the natural virus.

Insights into the Role of NS1 Protein

  • The researchers tested the effects of varying the length of the NS1 protein. Previous research in human influenza had found that a virus lacking the NS1 gene could only replicate in interferon (IFN)-incompetent systems, suggesting that the NS1 gene had a role in inhibiting this replication.
  • However, the study’s results with equine influenza virus demonstrated that the length of the NS1 protein didn’t correlate with the level of attenuation, or weakening, of the virus which contradicted earlier assumptions.
  • Moreover, a shorter NS1 protein led to the least attenuation, suggesting that the NS1 protein’s size isn’t necessarily an indicator of the virus’ virulence.
  • Therefore, they hypothesized that the attenuation of equine NS1 mutant viruses is more related to their level of NS1 protein expression rather than their length.

Potential Implications for Live Equine Influenza Vaccine

  • The study concludes that the newly created mutant viruses are impaired in their ability to inhibit IFN production in vitro. They also found that these mutants can’t replicate as efficiently as the parental recombinant strain in various mediums like embryonated hen eggs, MDCK cells, or in a mouse model.
  • Due to these characteristics, the research considers the attenuated mutant NS1 viruses potential candidates for creating a live equine influenza vaccine. As they are weakened and less able to inhibit IFN, they could possibly stimulate an immune response without causing the disease, which forms the basis for a possible live vaccine.

Cite This Article

APA
Quinlivan M, Zamarin D, Garcu00eda-Sastre A, Cullinane A, Chambers T, Palese P. (2005). Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol, 79(13), 8431-8439. https://doi.org/10.1128/JVI.79.13.8431-8439.2005

Publication

Journal of virology
ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 79
Issue: 13
Pages: 8431-8439

Researcher Affiliations

Quinlivan, Michelle
  • Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, New York 10029, USA.
Zamarin, Dmitriy
    Garcu00eda-Sastre, Adolfo
      Cullinane, Ann
        Chambers, Thomas
          Palese, Peter

            MeSH Terms

            • Animals
            • Cell Line
            • Dogs
            • Horses
            • Influenza A virus / genetics
            • Influenza A virus / physiology
            • Kidney
            • Polymerase Chain Reaction
            • Recombination, Genetic
            • Sequence Deletion
            • Viral Nonstructural Proteins / genetics

            Grant Funding

            • P42 ES007384 / NIEHS NIH HHS
            • T32 AI007647 / NIAID NIH HHS
            • AI007647 / NIAID NIH HHS
            • P42ES007384 / NIEHS NIH HHS

            References

            This article includes 38 references
            1. Aragu00f3n T, de la Luna S, Novoa I, Carrasco L, Ortu00edn J, Nieto A. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.. Mol Cell Biol 2000 Sep;20(17):6259-68.
              pmc: PMC86100pubmed: 10938102doi: 10.1128/MCB.20.17.6259-6268.2000google scholar: lookup
            2. Donelan NR, Basler CF, Garcu00eda-Sastre A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.. J Virol 2003 Dec;77(24):13257-66.
              pmc: PMC296096pubmed: 14645582doi: 10.1128/jvi.77.24.13257-13266.2003google scholar: lookup
            3. Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, Grassauer A, Alexandrova G, Katinger H, Muster T. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells.. J Virol 1998 Aug;72(8):6437-41.
              pmc: PMC109801pubmed: 9658085doi: 10.1128/JVI.72.8.6437-6441.1998google scholar: lookup
            4. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcu00eda-Sastre A. Rescue of influenza A virus from recombinant DNA.. J Virol 1999 Nov;73(11):9679-82.
              pmc: PMC113010pubmed: 10516084doi: 10.1128/JVI.73.11.9679-9682.1999google scholar: lookup
            5. Garcu00eda-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.. Virology 1998 Dec 20;252(2):324-30.
              pubmed: 9878611doi: 10.1006/viro.1998.9508google scholar: lookup
            6. Gorse GJ, Belshe RB. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.. J Clin Microbiol 1990 Nov;28(11):2539-50.
              pmc: PMC268221pubmed: 2123886doi: 10.1128/jcm.28.11.2539-2550.1990google scholar: lookup
            7. Gorse GJ, Campbell MJ, Otto EE, Powers DC, Chambers GW, Newman FK. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine.. J Infect Dis 1995 Jul;172(1):1-10.
              pubmed: 7797897doi: 10.1093/infdis/172.1.1google scholar: lookup
            8. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids.. Proc Natl Acad Sci U S A 2000 May 23;97(11):6108-13.
              pmc: PMC18566pubmed: 10801978doi: 10.1073/pnas.100133697google scholar: lookup
            9. Kittel C, Sereinig S, Ferko B, Stasakova J, Romanova J, Wolkerstorfer A, Katinger H, Egorov A. Rescue of influenza virus expressing GFP from the NS1 reading frame.. Virology 2004 Jun 20;324(1):67-73.
              pubmed: 15183054doi: 10.1016/j.virol.2004.03.035google scholar: lookup
            10. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.. Immunity 2001 Apr;14(4):461-70.
              pubmed: 11336691doi: 10.1016/s1074-7613(01)00126-1google scholar: lookup
            11. Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.. J Infect Dis 1999 May;179(5):1132-8.
              pubmed: 10191214doi: 10.1086/314713google scholar: lookup
            12. Lu00f3pez CB, Garcu00eda-Sastre A, Williams BR, Moran TM. Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses.. J Infect Dis 2003 Apr 1;187(7):1126-36.
              pubmed: 12660927doi: 10.1086/368381google scholar: lookup
            13. Lu Y, Qian XY, Krug RM. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing.. Genes Dev 1994 Aug 1;8(15):1817-28.
              pubmed: 7958859doi: 10.1101/gad.8.15.1817google scholar: lookup
            14. Lunn DP, Hussey S, Sebing R, Rushlow KE, Radecki SV, Whitaker-Dowling P, Youngner JS, Chambers TM, Holland RE Jr, Horohov DW. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.. J Am Vet Med Assoc 2001 Mar 15;218(6):900-6.
              pubmed: 11294315doi: 10.2460/javma.2001.218.900google scholar: lookup
            15. Maassab HF, Bryant ML. The development of live attenuated cold-adapted influenza virus vaccine for humans.. Rev Med Virol 1999 Oct-Dec;9(4):237-44.
              pubmed: 10578119doi: 10.1002/(sici)1099-1654(199910/12)9:4<237::aid-rmv252>3.0.co;2-ggoogle scholar: lookup
            16. Morahan PS, Grossberg SE. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.. J Infect Dis 1970 Jun;121(6):615-23.
              pubmed: 4316147doi: 10.1093/infdis/121.6.615google scholar: lookup
            17. Morley PS, Townsend HG, Bogdan JR, Haines DM. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.. J Am Vet Med Assoc 1999 Jul 1;215(1):61-6.
              pubmed: 10397067
            18. Mumford EL, Traub-Dargatz JL, Salman MD, Collins JK, Getzy DM, Carman J. Monitoring and detection of acute viral respiratory tract disease in horses.. J Am Vet Med Assoc 1998 Aug 1;213(3):385-90.
              pubmed: 9702229
            19. Nelson KM, Schram BR, McGregor MW, Sheoran AS, Olsen CW, Lunn DP. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.. Vaccine 1998 Aug;16(13):1306-13.
              pubmed: 9682395doi: 10.1016/s0264-410x(98)00009-7google scholar: lookup
            20. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.. Mol Cell 1998 Jun;1(7):991-1000.
              pubmed: 9651582doi: 10.1016/s1097-2765(00)80099-4google scholar: lookup
            21. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs.. Proc Natl Acad Sci U S A 1999 Aug 3;96(16):9345-50.
              pmc: PMC17785pubmed: 10430945doi: 10.1073/pnas.96.16.9345google scholar: lookup
            22. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector.. Gene 1991 Dec 15;108(2):193-9.
              pubmed: 1660837doi: 10.1016/0378-1119(91)90434-dgoogle scholar: lookup
            23. Park MS, Garcu00eda-Sastre A, Cros JF, Basler CF, Palese P. Newcastle disease virus V protein is a determinant of host range restriction.. J Virol 2003 Sep;77(17):9522-32.
              pmc: PMC187425pubmed: 12915566doi: 10.1128/jvi.77.17.9522-9532.2003google scholar: lookup
            24. Pleschka S, Jaskunas R, Engelhardt OG, Zu00fcrcher T, Palese P, Garcu00eda-Sastre A. A plasmid-based reverse genetics system for influenza A virus.. J Virol 1996 Jun;70(6):4188-92.
              pmc: PMC190316pubmed: 8648766doi: 10.1128/JVI.70.6.4188-4192.1996google scholar: lookup
            25. Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, Venditti M, Capone I, Seif I, De Maeyer E, Tough D, Donatelli I, Belardelli F. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.. J Immunol 2002 Jul 1;169(1):375-83.
              pubmed: 12077267doi: 10.4049/jimmunol.169.1.375google scholar: lookup
            26. Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure.. RNA 1995 Nov;1(9):948-56.
              pmc: PMC1369343pubmed: 8548659
            27. Qiu Y, Krug RM. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).. J Virol 1994 Apr;68(4):2425-32.
              pmc: PMC236720pubmed: 7908060doi: 10.1128/JVI.68.4.2425-2432.1994google scholar: lookup
            28. Sekellick MJ, Biggers WJ, Marcus PI. Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro.. In Vitro Cell Dev Biol 1990 Oct;26(10):997-1003.
              pubmed: 1700777doi: 10.1007/BF02624475google scholar: lookup
            29. Sekellick MJ, Marcus PI. Interferon induction by viruses. XIV. Development of interferon inducibility and its inhibition in chick embryo cells "aged" in vitro.. J Interferon Res 1985 Fall;5(4):651-67.
              pubmed: 2418133doi: 10.1089/jir.1985.5.651google scholar: lookup
            30. Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses.. Virus Res 2004 Jul;103(1-2):107-13.
              pubmed: 15163498doi: 10.1016/j.virusres.2004.02.022google scholar: lookup
            31. Soboll G, Nelson KM, Leuthner ES, Clark RJ, Drape R, Macklin MD, Swain WF, Olsen CW, Lunn DP. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.. Vaccine 2003 Jun 20;21(21-22):3081-92.
              pubmed: 12798652doi: 10.1016/s0264-410x(03)00161-0google scholar: lookup
            32. SOVINOVA O, TUMOVA B, POUSKA F, NEMEC J. Isolation of a virus causing respiratory disease in horses.. Acta Virol 1958 Jan-Mar;2(1):52-61.
              pubmed: 13533033
            33. Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.. Cancer Cell 2003 Oct;4(4):263-75.
              pubmed: 14585354doi: 10.1016/s1535-6108(03)00241-1google scholar: lookup
            34. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, Garcu00eda-Sastre A, Palese P. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.. Proc Natl Acad Sci U S A 2000 Apr 11;97(8):4309-14.
              pmc: PMC18238pubmed: 10725408doi: 10.1073/pnas.070525997google scholar: lookup
            35. Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials.. Equine Vet J 2001 Nov;33(7):637-43.
              pubmed: 11770983doi: 10.2746/042516401776249354google scholar: lookup
            36. WADDELL GH, TEIGLAND MB, SIGEL MM. A NEW INFLUENZA VIRUS ASSOCIATED WITH EQUINE RESPIRATORY DISEASE.. J Am Vet Med Assoc 1963 Sep 15;143:587-90.
              pubmed: 14077956
            37. Wang X, Basler CF, Williams BR, Silverman RH, Palese P, Garcu00eda-Sastre A. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains.. J Virol 2002 Dec;76(24):12951-62.
              pmc: PMC136679pubmed: 12438621doi: 10.1128/jvi.76.24.12951-12962.2002google scholar: lookup
            38. Webster RG. Are equine 1 influenza viruses still present in horses?. Equine Vet J 1993 Nov;25(6):537-8.
              pubmed: 8276003doi: 10.1111/j.2042-3306.1993.tb03009.xgoogle scholar: lookup

            Citations

            This article has been cited 139 times.
            1. Su CM, Du Y, Rowland RRR, Wang Q, Yoo D. Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses.. Front Immunol 2023;14:1172000.
              doi: 10.3389/fimmu.2023.1172000pubmed: 37138878google scholar: lookup
            2. Aslam S, Rajendran M, Kriti D, Kurland A, Johnson J, van Bakel H, Krammer F, Garcu00eda-Sastre A, Ayllon J. Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs.. NPJ Vaccines 2023 Feb 10;8(1):12.
              doi: 10.1038/s41541-023-00603-3pubmed: 36765053google scholar: lookup
            3. Bonifacio JPPL, Williams N, Garnier L, Hugues S, Schmolke M, Mazel-Sanchez B. Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.. J Virol 2022 Oct 26;96(20):e0087122.
              doi: 10.1128/jvi.00871-22pubmed: 36190240google scholar: lookup
            4. Nogales A, DeDiego ML, Martu00ednez-Sobrido L. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.. Front Cell Infect Microbiol 2022;12:954811.
              doi: 10.3389/fcimb.2022.954811pubmed: 35937688google scholar: lookup
            5. Chiu YF, Huang YW, Chen CY, Chen YC, Gong YN, Kuo RL, Huang CG, Shih SR. Visualizing Influenza A Virus vRNA Replication.. Front Microbiol 2022;13:812711.
              doi: 10.3389/fmicb.2022.812711pubmed: 35733972google scholar: lookup
            6. Nogales A, Chiem K, Breen M, DeDiego ML, Parrish CR, Martu00ednez-Sobrido L. Generation and Characterization of Single-Cycle Infectious Canine Influenza A Virus (sciCIV) and Its Use as Vaccine Platform.. Methods Mol Biol 2022;2465:227-255.
              doi: 10.1007/978-1-0716-2168-4_13pubmed: 35118625google scholar: lookup
            7. Mazel-Sanchez B, Iwaszkiewicz J, Bonifacio JPP, Silva F, Niu C, Strohmeier S, Eletto D, Krammer F, Tan G, Zoete V, Hale BG, Schmolke M. Influenza A viruses balance ER stress with host protein synthesis shutoff.. Proc Natl Acad Sci U S A 2021 Sep 7;118(36).
              doi: 10.1073/pnas.2024681118pubmed: 34479996google scholar: lookup
            8. Oladunni FS, Oseni SO, Martinez-Sobrido L, Chambers TM. Equine Influenza Virus and Vaccines.. Viruses 2021 Aug 20;13(8).
              doi: 10.3390/v13081657pubmed: 34452521google scholar: lookup
            9. Tam EH, Liu YC, Woung CH, Liu HM, Wu GH, Wu CC, Kuo RL. Role of the Chaperone Protein 14-3-3u03b5 in the Regulation of Influenza A Virus-Activated Beta Interferon.. J Virol 2021 Sep 27;95(20):e0023121.
              doi: 10.1128/JVI.00231-21pubmed: 34379499google scholar: lookup
            10. Nogales A, Schotsaert M, Rathnasinghe R, DeDiego ML, Garcu00eda-Sastre A, Martinez-Sobrido L. Replication-Competent u0394NS1 Influenza A Viruses Expressing Reporter Genes.. Viruses 2021 Apr 17;13(4).
              doi: 10.3390/v13040698pubmed: 33920517google scholar: lookup
            11. Vasilyev K, Shurygina AP, Sergeeva M, Stukova M, Egorov A. Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.. Microorganisms 2021 Mar 26;9(4).
              doi: 10.3390/microorganisms9040690pubmed: 33810549google scholar: lookup
            12. Holwerda M, Laloli L, Wider M, Schu00f6necker L, Becker J, Meylan M, Dijkman R. Establishment of a Reverse Genetic System from a Bovine Derived Influenza D Virus Isolate.. Viruses 2021 Mar 18;13(3).
              doi: 10.3390/v13030502pubmed: 33803792google scholar: lookup
            13. Ghorbani A, Abundo MC, Ji H, Taylor KJM, Ngunjiri JM, Lee CW. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.. J Virol 2020 Dec 22;95(2).
              doi: 10.1128/JVI.01722-20pubmed: 33115873google scholar: lookup
            14. Hilimire TA, Nogales A, Chiem K, Ortego J, Martinez-Sobrido L. Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine.. Pathogens 2020 Jan 29;9(2).
              doi: 10.3390/pathogens9020086pubmed: 32013198google scholar: lookup
            15. Yang H, Wang Y, Ye C. Rapid Generation of Attenuated Infectious Bursal Disease Virus from Dual-Promoter Plasmids by Reduction of Viral Ribonucleoprotein Activity.. J Virol 2020 Mar 17;94(7).
              doi: 10.1128/JVI.01569-19pubmed: 31915284google scholar: lookup
            16. Jureka AS, Kleinpeter AB, Tipper JL, Harrod KS, Petit CM. The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I.. J Biol Chem 2020 Jan 24;295(4):1153-1164.
              doi: 10.1074/jbc.RA119.011410pubmed: 31843969google scholar: lookup
            17. Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.. Viruses 2019 Oct 11;11(10).
              doi: 10.3390/v11100933pubmed: 31614538google scholar: lookup
            18. Calderon BM, Danzy S, Delima GK, Jacobs NT, Ganti K, Hockman MR, Conn GL, Lowen AC, Steel J. Dysregulation of M segment gene expression contributes to influenza A virus host restriction.. PLoS Pathog 2019 Aug;15(8):e1007892.
              doi: 10.1371/journal.ppat.1007892pubmed: 31415678google scholar: lookup
            19. Chambers BS, Heaton BE, Rausch K, Dumm RE, Hamilton JR, Cherry S, Heaton NS. DNA mismatch repair is required for the host innate response and controls cellular fate after influenza virus infection.. Nat Microbiol 2019 Nov;4(11):1964-1977.
              doi: 10.1038/s41564-019-0509-3pubmed: 31358986google scholar: lookup
            20. Kim JI, Lee S, Lee GY, Park S, Bae JY, Heo J, Kim HY, Woo SH, Lee HU, Ahn CA, Bang HJ, Ju HS, Ok K, Byun Y, Cho DJ, Shin JS, Kim DY, Park MS, Park MS. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.. J Virol 2019 Sep 1;93(17).
              doi: 10.1128/JVI.00878-19pubmed: 31167918google scholar: lookup
            21. Blanco-Lobo P, Nogales A, Rodru00edguez L, Martu00ednez-Sobrido L. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.. Viruses 2019 Feb 22;11(2).
              doi: 10.3390/v11020190pubmed: 30813325google scholar: lookup
            22. Dumm RE, Fiege JK, Waring BM, Kuo CT, Langlois RA, Heaton NS. Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function.. Nat Commun 2019 Feb 15;10(1):779.
              doi: 10.1038/s41467-019-08617-zpubmed: 30770807google scholar: lookup
            23. Wei J, Kishton RJ, Angel M, Conn CS, Dalla-Venezia N, Marcel V, Vincent A, Catez F, Ferru00e9 S, Ayadi L, Marchand V, Dersh D, Gibbs JS, Ivanov IP, Fridlyand N, Coutu00e9 Y, Diaz JJ, Qian SB, Staudt LM, Restifo NP, Yewdell JW. Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.. Mol Cell 2019 Mar 21;73(6):1162-1173.e5.
              doi: 10.1016/j.molcel.2018.12.020pubmed: 30712990google scholar: lookup
            24. Rahim MN, Klewes L, Zahedi-Amiri A, Mai S, Coombs KM. Global Interactomics Connect Nuclear Mitotic Apparatus Protein NUMA1 to Influenza Virus Maturation.. Viruses 2018 Dec 19;10(12).
              doi: 10.3390/v10120731pubmed: 30572664google scholar: lookup
            25. Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.. Viruses 2018 Dec 12;10(12).
              doi: 10.3390/v10120708pubmed: 30545063google scholar: lookup
            26. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.. Front Microbiol 2018;9:1941.
              doi: 10.3389/fmicb.2018.01941pubmed: 30237788google scholar: lookup
            27. Nogales A, Martinez-Sobrido L, Chiem K, Topham DJ, DeDiego ML. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.. J Virol 2018 Oct 1;92(19).
              doi: 10.1128/JVI.01206-18pubmed: 30021892google scholar: lookup
            28. Tsai K, Courtney DG, Kennedy EM, Cullen BR. Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replication.. RNA 2018 Sep;24(9):1172-1182.
              doi: 10.1261/rna.066332.118pubmed: 29903832google scholar: lookup
            29. Fulton BO, Sun W, Heaton NS, Palese P. The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus.. J Virol 2018 Aug 15;92(16).
              doi: 10.1128/JVI.00754-18pubmed: 29899093google scholar: lookup
            30. Wei X, Qian W, Sizhu S, Li Y, Guo K, Jin M, Zhou H. Negative Regulation of Interferon-u03b2 Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks.. Front Immunol 2018;9:409.
              doi: 10.3389/fimmu.2018.00409pubmed: 29599773google scholar: lookup
            31. Mazel-Sanchez B, Boal-Carvalho I, Silva F, Dijkman R, Schmolke M. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.. J Virol 2018 Jun 1;92(11).
              doi: 10.1128/JVI.00425-18pubmed: 29563290google scholar: lookup
            32. Aydillo T, Ayllon J, Pavlisin A, Martinez-Romero C, Tripathi S, Mena I, Moreira-Soto A, Vicente-Santos A, Corrales-Aguilar E, Schwemmle M, Garcu00eda-Sastre A. Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.. J Virol 2018 Apr 1;92(7).
              doi: 10.1128/JVI.02021-17pubmed: 29321309google scholar: lookup
            33. White KM, Abreu P Jr, Wang H, De Jesus PD, Manicassamy B, Garcu00eda-Sastre A, Chanda SK, DeVita RJ, Shaw ML. Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.. ACS Infect Dis 2018 Feb 9;4(2):146-157.
              doi: 10.1021/acsinfecdis.7b00120pubmed: 29268608google scholar: lookup
            34. Chauchu00e9 C, Nogales A, Zhu H, Goldfarb D, Ahmad Shanizza AI, Gu Q, Parrish CR, Martu00ednez-Sobrido L, Marshall JF, Murcia PR. Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1.. J Virol 2018 Mar 1;92(5).
              doi: 10.1128/JVI.01875-17pubmed: 29237841google scholar: lookup
            35. Clark AM, DeDiego ML, Anderson CS, Wang J, Yang H, Nogales A, Martinez-Sobrido L, Zand MS, Sangster MY, Topham DJ. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.. PLoS One 2017;12(11):e0188267.
              doi: 10.1371/journal.pone.0188267pubmed: 29145498google scholar: lookup
            36. Gahan J, Garvey M, Gildea S, Gu00fcr E, Kagankaya A, Cullinane A. Whole-genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey.. Influenza Other Respir Viruses 2018 May;12(3):374-382.
              doi: 10.1111/irv.12485pubmed: 28940727google scholar: lookup
            37. Courtney DG, Kennedy EM, Dumm RE, Bogerd HP, Tsai K, Heaton NS, Cullen BR. Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication.. Cell Host Microbe 2017 Sep 13;22(3):377-386.e5.
              doi: 10.1016/j.chom.2017.08.004pubmed: 28910636google scholar: lookup
            38. Chen S, Zhu Y, Yang D, Yang Y, Shi S, Qin T, Peng D, Liu X. Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses.. Front Microbiol 2017;8:1086.
              doi: 10.3389/fmicb.2017.01086pubmed: 28659900google scholar: lookup
            39. Nogales A, Rodriguez L, DeDiego ML, Topham DJ, Martu00ednez-Sobrido L. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.. J Virol 2017 Sep 1;91(17).
              doi: 10.1128/JVI.00720-17pubmed: 28637750google scholar: lookup
            40. Wang BX, Wei L, Kotra LP, Brown EG, Fish EN. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.. Viruses 2017 May 12;9(5).
              doi: 10.3390/v9050107pubmed: 28498306google scholar: lookup
            41. Nogales A, Martu00ednez-Sobrido L. Reverse Genetics Approaches for the Development of Influenza Vaccines.. Int J Mol Sci 2016 Dec 22;18(1).
              doi: 10.3390/ijms18010020pubmed: 28025504google scholar: lookup
            42. Nogales A, Rodriguez L, Chauchu00e9 C, Huang K, Reilly EC, Topham DJ, Murcia PR, Parrish CR, Martu00ednez-Sobrido L. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.. J Virol 2017 Feb 15;91(4).
              doi: 10.1128/JVI.02211-16pubmed: 27928017google scholar: lookup
            43. Li Y, Basavappa M, Lu J, Dong S, Cronkite DA, Prior JT, Reinecker HC, Hertzog P, Han Y, Li WX, Cheloufi S, Karginov FV, Ding SW, Jeffrey KL. Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells.. Nat Microbiol 2016 Dec 5;2:16250.
              doi: 10.1038/nmicrobiol.2016.250pubmed: 27918527google scholar: lookup
            44. Barba M, Daly JM. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?. Pathogens 2016 Aug 31;5(3).
              doi: 10.3390/pathogens5030057pubmed: 27589809google scholar: lookup
            45. Fleming SB. Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.. Vaccines (Basel) 2016 Jun 29;4(3).
              doi: 10.3390/vaccines4030023pubmed: 27367734google scholar: lookup
            46. Kuo RL, Li LH, Lin SJ, Li ZH, Chen GW, Chang CK, Wang YR, Tam EH, Gong YN, Krug RM, Shih SR. Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation.. J Virol 2016 May;90(9):4696-4705.
              doi: 10.1128/JVI.02843-15pubmed: 26912617google scholar: lookup
            47. Breen M, Nogales A, Baker SF, Perez DR, Martu00ednez-Sobrido L. Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies.. PLoS One 2016;11(1):e0147723.
              doi: 10.1371/journal.pone.0147723pubmed: 26809059google scholar: lookup
            48. Boukharta M, Azlmat S, Elharrak M, Ennaji MM. Multiple alignment comparison of the non-structural genes of three strains of equine influenza viruses (H3N8) isolated in Morocco.. BMC Res Notes 2015 Sep 24;8:471.
              doi: 10.1186/s13104-015-1441-0pubmed: 26404167google scholar: lookup
            49. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination.. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
              doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
            50. Ngunjiri JM, Ali A, Boyaka P, Marcus PI, Lee CW. In vivo assessment of NS1-truncated influenza virus with a novel SLSYSINWRH motif as a self-adjuvanting live attenuated vaccine.. PLoS One 2015;10(3):e0118934.
              doi: 10.1371/journal.pone.0118934pubmed: 25790187google scholar: lookup
            51. Sun H, Cui P, Song Y, Qi Y, Li X, Qi W, Xu C, Jiao P, Liao M. PB2 segment promotes high-pathogenicity of H5N1 avian influenza viruses in mice.. Front Microbiol 2015;6:73.
              doi: 10.3389/fmicb.2015.00073pubmed: 25713566google scholar: lookup
            52. Henry Dunand CJ, Leon PE, Kaur K, Tan GS, Zheng NY, Andrews S, Huang M, Qu X, Huang Y, Salgado-Ferrer M, Ho IY, Taylor W, Hai R, Wrammert J, Ahmed R, Garcu00eda-Sastre A, Palese P, Krammer F, Wilson PC. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.. J Clin Invest 2015 Mar 2;125(3):1255-68.
              doi: 10.1172/JCI74374pubmed: 25689254google scholar: lookup
            53. Nogales A, Baker SF, Martu00ednez-Sobrido L. Replication-competent influenza A viruses expressing a red fluorescent protein.. Virology 2015 Feb;476:206-216.
              doi: 10.1016/j.virol.2014.12.006pubmed: 25553516google scholar: lookup
            54. Riegger D, Hai R, Dornfeld D, Mu00e4nz B, Leyva-Grado V, Su00e1nchez-Aparicio MT, Albrecht RA, Palese P, Haller O, Schwemmle M, Garcu00eda-Sastre A, Kochs G, Schmolke M. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.. J Virol 2015 Feb;89(4):2241-52.
              doi: 10.1128/JVI.02406-14pubmed: 25505067google scholar: lookup
            55. Seladi-Schulman J, Campbell PJ, Suppiah S, Steel J, Lowen AC. Filament-producing mutants of influenza A/Puerto Rico/8/1934 (H1N1) virus have higher neuraminidase activities than the spherical wild-type.. PLoS One 2014;9(11):e112462.
              doi: 10.1371/journal.pone.0112462pubmed: 25383873google scholar: lookup
            56. Atasheva S, Kim DY, Frolova EI, Frolov I. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.. J Virol 2015 Jan;89(1):71-82.
              doi: 10.1128/JVI.02252-14pubmed: 25320296google scholar: lookup
            57. Zhou B, Ma J, Liu Q, Bawa B, Wang W, Shabman RS, Duff M, Lee J, Lang Y, Cao N, Nagy A, Lin X, Stockwell TB, Richt JA, Wentworth DE, Ma W. Characterization of uncultivable bat influenza virus using a replicative synthetic virus.. PLoS Pathog 2014 Oct;10(10):e1004420.
              doi: 10.1371/journal.ppat.1004420pubmed: 25275541google scholar: lookup
            58. Danzy S, Studdard LR, Manicassamy B, Solorzano A, Marshall N, Garcu00eda-Sastre A, Steel J, Lowen AC. Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.. J Virol 2014 Nov;88(22):13436-46.
              doi: 10.1128/JVI.01093-14pubmed: 25210184google scholar: lookup
            59. Nogales A, Baker SF, Ortiz-Riau00f1o E, Dewhurst S, Topham DJ, Martu00ednez-Sobrido L. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.. J Virol 2014 Sep;88(18):10525-40.
              doi: 10.1128/JVI.01565-14pubmed: 24965472google scholar: lookup
            60. Wei L, Cui J, Song Y, Zhang S, Han F, Yuan R, Gong L, Jiao P, Liao M. Duck MDA5 functions in innate immunity against H5N1 highly pathogenic avian influenza virus infections.. Vet Res 2014 Jun 18;45(1):66.
              doi: 10.1186/1297-9716-45-66pubmed: 24939427google scholar: lookup
            61. Campbell PJ, Kyriakis CS, Marshall N, Suppiah S, Seladi-Schulman J, Danzy S, Lowen AC, Steel J. Residue 41 of the Eurasian avian-like swine influenza a virus matrix protein modulates virion filament length and efficiency of contact transmission.. J Virol 2014 Jul;88(13):7569-77.
              doi: 10.1128/JVI.00119-14pubmed: 24760887google scholar: lookup
            62. Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, Barr IG, Wentworth DE. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics.. J Clin Microbiol 2014 May;52(5):1330-7.
              doi: 10.1128/JCM.03265-13pubmed: 24501036google scholar: lookup
            63. Vergara-Alert J, Busquets N, Ballester M, Chaves AJ, Rivas R, Dolz R, Wang Z, Pleschka S, Maju00f3 N, Rodru00edguez F, Darji A. The NS segment of H5N1 avian influenza viruses (AIV) enhances the virulence of an H7N1 AIV in chickens.. Vet Res 2014 Jan 25;45(1):7.
              doi: 10.1186/1297-9716-45-7pubmed: 24460592google scholar: lookup
            64. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solu00f3rzano A, Garcu00eda-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.. Nat Commun 2013;4:2854.
              doi: 10.1038/ncomms3854pubmed: 24326875google scholar: lookup
            65. Zhou B, Pearce MB, Li Y, Wang J, Mason RJ, Tumpey TM, Wentworth DE. Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus.. PLoS One 2013;8(6):e67616.
              doi: 10.1371/journal.pone.0067616pubmed: 23799150google scholar: lookup
            66. Detournay O, Morrison DA, Wagner B, Zarnegar B, Wattrang E. Genomic analysis and mRNA expression of equine type I interferon genes.. J Interferon Cytokine Res 2013 Dec;33(12):746-59.
              doi: 10.1089/jir.2012.0130pubmed: 23772953google scholar: lookup
            67. Medina RA, Stertz S, Manicassamy B, Zimmermann P, Sun X, Albrecht RA, Uusi-Kerttula H, Zagordi O, Belshe RB, Frey SE, Tumpey TM, Garcu00eda-Sastre A. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.. Sci Transl Med 2013 May 29;5(187):187ra70.
              doi: 10.1126/scitranslmed.3005996pubmed: 23720581google scholar: lookup
            68. Jang YH, Seong BL. Principles underlying rational design of live attenuated influenza vaccines.. Clin Exp Vaccine Res 2012 Jul;1(1):35-49.
              doi: 10.7774/cevr.2012.1.1.35pubmed: 23596576google scholar: lookup
            69. Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.. J Virol 2013 Jun;87(12):6542-50.
              doi: 10.1128/JVI.00641-13pubmed: 23576508google scholar: lookup
            70. Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.. Cell Host Microbe 2013 Mar 13;13(3):314-23.
              doi: 10.1016/j.chom.2013.02.008pubmed: 23498956google scholar: lookup
            71. Ortiz-Riau00f1o E, Cheng BYH, Carlos de la Torre J, Martu00ednez-Sobrido L. Arenavirus reverse genetics for vaccine development.. J Gen Virol 2013 Jun;94(Pt 6):1175-1188.
              doi: 10.1099/vir.0.051102-0pubmed: 23364194google scholar: lookup
            72. Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villu00e1n E, Garcu00eda-Sastre A, Gack MU. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.. PLoS Pathog 2012;8(11):e1003059.
              doi: 10.1371/journal.ppat.1003059pubmed: 23209422google scholar: lookup
            73. Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.. J Virol 2012 Oct;86(19):10293-301.
              doi: 10.1128/JVI.01131-12pubmed: 22787224google scholar: lookup
            74. Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P Jr, Ayllon J, Palese P, Shaw ML. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.. PLoS Pathog 2012;8(4):e1002668.
              doi: 10.1371/journal.ppat.1002668pubmed: 22577360google scholar: lookup
            75. Gao Q, Chou YY, Dou011fanay S, Vafabakhsh R, Ha T, Palese P. The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging.. J Virol 2012 Jul;86(13):7043-51.
              doi: 10.1128/JVI.00662-12pubmed: 22532680google scholar: lookup
            76. Kesic MJ, Meyer M, Bauer R, Jaspers I. Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.. PLoS One 2012;7(4):e35108.
              doi: 10.1371/journal.pone.0035108pubmed: 22496898google scholar: lookup
            77. Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.. J Biol Chem 2012 Jun 22;287(26):22015-29.
              doi: 10.1074/jbc.M111.319996pubmed: 22493439google scholar: lookup
            78. Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, Garcu00eda-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression.. J Virol 2012 May;86(10):5782-90.
              doi: 10.1128/JVI.00190-12pubmed: 22398291google scholar: lookup
            79. Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes.. J Virol 2012 May;86(10):5774-81.
              doi: 10.1128/JVI.00137-12pubmed: 22398287google scholar: lookup
            80. Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, Garcu00eda-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.. Proc Natl Acad Sci U S A 2012 Feb 14;109(7):2573-8.
              doi: 10.1073/pnas.1200039109pubmed: 22308500google scholar: lookup
            81. Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, Garcu00eda-Sastre A, Palese P, Hai R. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model.. J Virol 2011 Nov;85(21):11235-41.
              doi: 10.1128/JVI.05794-11pubmed: 21880744google scholar: lookup
            82. Penski N, Hu00e4rtle S, Rubbenstroth D, Krohmann C, Ruggli N, Schusser B, Pfann M, Reuter A, Gohrbandt S, Hundt J, Veits J, Breithaupt A, Kochs G, Stech J, Summerfield A, Vahlenkamp T, Kaspers B, Staeheli P. Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state.. J Virol 2011 Aug;85(15):7730-41.
              doi: 10.1128/JVI.00063-11pubmed: 21613402google scholar: lookup
            83. Tisoncik JR, Billharz R, Burmakina S, Belisle SE, Proll SC, Korth MJ, Garcu00eda-Sastre A, Katze MG. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways.. J Gen Virol 2011 Sep;92(Pt 9):2093-2104.
              doi: 10.1099/vir.0.032060-0pubmed: 21593271google scholar: lookup
            84. Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells.. Free Radic Biol Med 2011 Jul 15;51(2):444-53.
              doi: 10.1016/j.freeradbiomed.2011.04.027pubmed: 21549835google scholar: lookup
            85. Mansour M, Palese P, Zamarin D. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.. J Virol 2011 Jun;85(12):6015-23.
              doi: 10.1128/JVI.01537-10pubmed: 21471241google scholar: lookup
            86. Cullinane A, Elton D, Mumford J. Equine influenza - surveillance and control.. Influenza Other Respir Viruses 2010 Nov;4(6):339-44.
              doi: 10.1111/j.1750-2659.2010.00176.xpubmed: 20958927google scholar: lookup
            87. Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, Garcu00eda-Sastre A, Tumpey TM, Wentworth DE. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.. Vaccine 2010 Nov 23;28(50):8015-25.
              doi: 10.1016/j.vaccine.2010.08.106pubmed: 20934458google scholar: lookup
            88. Steidle S, Martu00ednez-Sobrido L, Mordstein M, Lienenklaus S, Garcu00eda-Sastre A, Stu00e4heli P, Kochs G. Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.. J Virol 2010 Dec;84(24):12761-70.
              doi: 10.1128/JVI.00701-10pubmed: 20926573google scholar: lookup
            89. Baum A, Sachidanandam R, Garcu00eda-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.. Proc Natl Acad Sci U S A 2010 Sep 14;107(37):16303-8.
              doi: 10.1073/pnas.1005077107pubmed: 20805493google scholar: lookup
            90. Martu00ednez-Sobrido L, Garcu00eda-Sastre A. Generation of recombinant influenza virus from plasmid DNA.. J Vis Exp 2010 Aug 3;(42).
              doi: 10.3791/2057pubmed: 20729804google scholar: lookup
            91. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, Garcu00eda-Sastre A, Palese P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain.. mBio 2010 May 18;1(1).
              doi: 10.1128/mBio.00018-10pubmed: 20689752google scholar: lookup
            92. Takayama E, Ono T, Carnero E, Umemoto S, Yamaguchi Y, Kanayama A, Oguma T, Takashima Y, Tadakuma T, Garcu00eda-Sastre A, Miyahira Y. Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.. Int J Parasitol 2010 Nov;40(13):1549-61.
              doi: 10.1016/j.ijpara.2010.05.011pubmed: 20620143google scholar: lookup
            93. Mueller S, Coleman JR, Papamichail D, Ward CB, Nimnual A, Futcher B, Skiena S, Wimmer E. Live attenuated influenza virus vaccines by computer-aided rational design.. Nat Biotechnol 2010 Jul;28(7):723-6.
              doi: 10.1038/nbt.1636pubmed: 20543832google scholar: lookup
            94. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, Garcu00eda-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.. Proc Natl Acad Sci U S A 2010 Jun 22;107(25):11531-6.
              doi: 10.1073/pnas.0914994107pubmed: 20534532google scholar: lookup
            95. Gao Q, Lowen AC, Wang TT, Palese P. A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins.. J Virol 2010 Aug;84(16):8062-71.
              doi: 10.1128/JVI.00722-10pubmed: 20519387google scholar: lookup
            96. Ma W, Lager KM, Lekcharoensuk P, Ulery ES, Janke BH, Solu00f3rzano A, Webby RJ, Garcu00eda-Sastre A, Richt JA. Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses.. J Gen Virol 2010 Sep;91(Pt 9):2314-21.
              doi: 10.1099/vir.0.021402-0pubmed: 20484565google scholar: lookup
            97. Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, Garcu00eda-Sastre A. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.. J Virol 2010 Jul;84(14):6909-22.
              doi: 10.1128/JVI.00081-10pubmed: 20444891google scholar: lookup
            98. Saenz RA, Quinlivan M, Elton D, Macrae S, Blunden AS, Mumford JA, Daly JM, Digard P, Cullinane A, Grenfell BT, McCauley JW, Wood JL, Gog JR. Dynamics of influenza virus infection and pathology.. J Virol 2010 Apr;84(8):3974-83.
              doi: 10.1128/JVI.02078-09pubmed: 20130053google scholar: lookup
            99. Hale BG, Albrecht RA, Garcu00eda-Sastre A. Innate immune evasion strategies of influenza viruses.. Future Microbiol 2010 Jan;5(1):23-41.
              doi: 10.2217/fmb.09.108pubmed: 20020828google scholar: lookup
            100. Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Hu00f6gner K, Herold S, Ludwig S, Wolff T, Yu K, Richt JA, Planz O, Pleschka S. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV.. J Virol 2010 Feb;84(4):2122-33.
              doi: 10.1128/JVI.01668-09pubmed: 20007264google scholar: lookup
            101. Mueller SN, Langley WA, Carnero E, Garcu00eda-Sastre A, Ahmed R. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses.. J Virol 2010 Feb;84(4):1847-55.
              doi: 10.1128/JVI.01317-09pubmed: 19939929google scholar: lookup
            102. Gannagu00e9 M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ru00e4mer PC, Lee M, Strowig T, Arrey F, Conenello G, Pypaert M, Andersen J, Garcu00eda-Sastre A, Mu00fcnz C. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.. Cell Host Microbe 2009 Oct 22;6(4):367-80.
              doi: 10.1016/j.chom.2009.09.005pubmed: 19837376google scholar: lookup
            103. Gao Q, Palese P. Rewiring the RNAs of influenza virus to prevent reassortment.. Proc Natl Acad Sci U S A 2009 Sep 15;106(37):15891-6.
              doi: 10.1073/pnas.0908897106pubmed: 19805230google scholar: lookup
            104. Kochs G, Martu00ednez-Sobrido L, Lienenklaus S, Weiss S, Garcu00eda-Sastre A, Staeheli P. Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene.. J Gen Virol 2009 Dec;90(Pt 12):2990-2994.
              doi: 10.1099/vir.0.015727-0pubmed: 19726611google scholar: lookup
            105. Martu00ednez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcu00eda-Sastre A, de la Torre JC. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.. J Virol 2009 Nov;83(21):11330-40.
              doi: 10.1128/JVI.00763-09pubmed: 19710144google scholar: lookup
            106. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, Wentworth DE. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.. J Virol 2009 Oct;83(19):10309-13.
              doi: 10.1128/JVI.01109-09pubmed: 19605485google scholar: lookup
            107. Marcus PI, Ngunjiri JM, Sekellick MJ. Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles.. J Virol 2009 Aug;83(16):8122-30.
              doi: 10.1128/JVI.02680-08pubmed: 19494019google scholar: lookup
            108. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, tenOever BR. MicroRNA-mediated species-specific attenuation of influenza A virus.. Nat Biotechnol 2009 Jun;27(6):572-6.
              doi: 10.1038/nbt.1542pubmed: 19483680google scholar: lookup
            109. Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.. Vaccine 2009 Jun 8;27(28):3766-74.
              doi: 10.1016/j.vaccine.2009.03.090pubmed: 19464560google scholar: lookup
            110. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcu00eda-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I.. Cell Host Microbe 2009 May 8;5(5):439-49.
              doi: 10.1016/j.chom.2009.04.006pubmed: 19454348google scholar: lookup
            111. Rolling T, Koerner I, Zimmermann P, Holz K, Haller O, Staeheli P, Kochs G. Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice.. J Virol 2009 Jul;83(13):6673-80.
              doi: 10.1128/JVI.00212-09pubmed: 19403683google scholar: lookup
            112. Haye K, Burmakina S, Moran T, Garcu00eda-Sastre A, Fernandez-Sesma A. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells.. J Virol 2009 Jul;83(13):6849-62.
              doi: 10.1128/JVI.02323-08pubmed: 19403682google scholar: lookup
            113. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, Garcu00eda-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.. Equine Vet J 2009 Jan;41(1):87-92.
              doi: 10.2746/042516408x371937pubmed: 19301588google scholar: lookup
            114. Rao SS, Styles D, Kong W, Andrews C, Gorres JP, Nabel GJ. A gene-based avian influenza vaccine in poultry.. Poult Sci 2009 Apr;88(4):860-6.
              doi: 10.3382/ps.2008-00360pubmed: 19276436google scholar: lookup
            115. Zamarin D, Martu00ednez-Sobrido L, Kelly K, Mansour M, Sheng G, Vigil A, Garcu00eda-Sastre A, Palese P, Fong Y. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses.. Mol Ther 2009 Apr;17(4):697-706.
              doi: 10.1038/mt.2008.286pubmed: 19209145google scholar: lookup
            116. Lowen AC, Steel J, Mubareka S, Carnero E, Garcu00eda-Sastre A, Palese P. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.. J Virol 2009 Apr;83(7):2803-18.
              doi: 10.1128/JVI.02424-08pubmed: 19153237google scholar: lookup
            117. Zohari S, Gyarmati P, Ejdersund A, Berglu00f6f U, Thoru00e9n P, Ehrenberg M, Czifra G, Belu00e1k S, Waldenstru00f6m J, Olsen B, Berg M. Phylogenetic analysis of the non-structural (NS) gene of influenza A viruses isolated from mallards in Northern Europe in 2005.. Virol J 2008 Dec 12;5:147.
              doi: 10.1186/1743-422X-5-147pubmed: 19077274google scholar: lookup
            118. Hai R, Martu00ednez-Sobrido L, Fraser KA, Ayllon J, Garcu00eda-Sastre A, Palese P. Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.. J Virol 2008 Nov;82(21):10580-90.
              doi: 10.1128/JVI.01213-08pubmed: 18768976google scholar: lookup
            119. Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, Garcu00eda-Sastre A, Saif YM, Lee CW. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry.. Vaccine 2008 Jul 4;26(29-30):3580-6.
              doi: 10.1016/j.vaccine.2008.05.001pubmed: 18539366google scholar: lookup
            120. Gao Q, Brydon EW, Palese P. A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF.. J Virol 2008 Jul;82(13):6419-26.
              doi: 10.1128/JVI.00514-08pubmed: 18448539google scholar: lookup
            121. Ilyinskii PO, Meriin AB, Gabai VL, Zhirnov OP, Thoidis G, Shneider AM. Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.. Vaccine 2008 Apr 24;26(18):2177-85.
              doi: 10.1016/j.vaccine.2008.02.050pubmed: 18400345google scholar: lookup
            122. Marsh GA, Rabadu00e1n R, Levine AJ, Palese P. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging.. J Virol 2008 Mar;82(5):2295-304.
              doi: 10.1128/JVI.02267-07pubmed: 18094182google scholar: lookup
            123. Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice.. J Virol 2008 Feb;82(3):1146-54.
              doi: 10.1128/JVI.01698-07pubmed: 18032512google scholar: lookup
            124. Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, Kawaoka Y, Chen H. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens.. J Virol 2008 Jan;82(1):220-8.
              doi: 10.1128/JVI.00978-07pubmed: 17942562google scholar: lookup
            125. Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng CT, Baker SC, Li K. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.. J Biol Chem 2007 Nov 2;282(44):32208-21.
              doi: 10.1074/jbc.M704870200pubmed: 17761676google scholar: lookup
            126. Baskin CR, Bielefeldt-Ohmann H, Garcu00eda-Sastre A, Tumpey TM, Van Hoeven N, Carter VS, Thomas MJ, Proll S, Solu00f3rzano A, Billharz R, Fornek JL, Thomas S, Chen CH, Clark EA, Murali-Krishna K, Katze MG. Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.. J Virol 2007 Nov;81(21):11817-27.
              doi: 10.1128/JVI.00590-07pubmed: 17715226google scholar: lookup
            127. Marsh GA, Hatami R, Palese P. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions.. J Virol 2007 Sep;81(18):9727-36.
              doi: 10.1128/JVI.01144-07pubmed: 17634232google scholar: lookup
            128. Newby CM, Sabin L, Pekosz A. The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells.. J Virol 2007 Sep;81(17):9469-80.
              doi: 10.1128/JVI.00989-07pubmed: 17596305google scholar: lookup
            129. Grimm D, Staeheli P, Hufbauer M, Koerner I, Martu00ednez-Sobrido L, Solu00f3rzano A, Garcu00eda-Sastre A, Haller O, Kochs G. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene.. Proc Natl Acad Sci U S A 2007 Apr 17;104(16):6806-11.
              doi: 10.1073/pnas.0701849104pubmed: 17426143google scholar: lookup
            130. Mibayashi M, Martu00ednez-Sobrido L, Loo YM, Cu00e1rdenas WB, Gale M Jr, Garcu00eda-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.. J Virol 2007 Jan;81(2):514-24.
              doi: 10.1128/JVI.01265-06pubmed: 17079289google scholar: lookup
            131. Ferko B, Kittel C, Romanova J, Sereinig S, Katinger H, Egorov A. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts.. J Virol 2006 Dec;80(23):11621-7.
              doi: 10.1128/JVI.01645-06pubmed: 16971432google scholar: lookup
            132. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z, Chen H. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses.. J Virol 2006 Nov;80(22):11115-23.
              doi: 10.1128/JVI.00993-06pubmed: 16971424google scholar: lookup
            133. Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solu00f3rzano A, Garcu00eda-Sastre A. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.. J Virol 2006 Nov;80(22):11009-18.
              doi: 10.1128/JVI.00787-06pubmed: 16943300google scholar: lookup
            134. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.. J Virol 2006 Aug;80(16):7976-83.
              doi: 10.1128/JVI.00415-06pubmed: 16873254google scholar: lookup
            135. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, Garcu00eda-Sastre A, Moran TM. Influenza virus evades innate and adaptive immunity via the NS1 protein.. J Virol 2006 Jul;80(13):6295-304.
              doi: 10.1128/JVI.02381-05pubmed: 16775317google scholar: lookup
            136. Palese P. Making better influenza virus vaccines?. Emerg Infect Dis 2006 Jan;12(1):61-5.
              doi: 10.3201/eid1201.051043pubmed: 16494719google scholar: lookup
            137. Garcu00eda-Sastre A. Antiviral response in pandemic influenza viruses.. Emerg Infect Dis 2006 Jan;12(1):44-7.
              doi: 10.3201/eid1201.051186pubmed: 16494716google scholar: lookup
            138. Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.. J Virol 2006 Mar;80(5):2396-404.
              doi: 10.1128/JVI.80.5.2396-2404.2006pubmed: 16474146google scholar: lookup
            139. Efferson CL, Tsuda N, Kawano K, Nistal-Villu00e1n E, Sellappan S, Yu D, Murray JL, Garcu00eda-Sastre A, Ioannides CG. Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.. J Virol 2006 Jan;80(1):383-94.
              doi: 10.1128/JVI.80.1.383-394.2006pubmed: 16352563google scholar: lookup

            Secure Payments

            PayPal Visa Mastercard American Express

            Satisfaction Guarantee

            We offer a 60-day guarantee to ensure you are completely satisfied.

            Fast & Free Shipping

            We provide fast and free shipping on all orders over $40.

            Use Nutrition Calculator
            Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
            Talk to a Nutritionist
            Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
            Submit Diet Evaluation
            Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists